tiprankstipranks
Trending News
More News >
InnoCan Pharma (TSE:INNO)
:INNO

InnoCan Pharma (INNO) Revenue

Compare
21 Followers

InnoCan Pharma Revenue

InnoCan Pharma had a revenue of 9.40M in the quarter ending Sep 30, 2025, with 34.11%. This bring the company's revenue in the last twelve months to 29.60M, Decreased 2.68%. In the fiscal year ending Dec 31, 2024, InnoCan Pharma had annual revenue of 29.44M with 115.55% growth.
Revenue (ttm)
29.60M
Revenue Growth
-3.94%
P/S Ratio
1.15
Revenue/Employee
C$2,676,091
Employees
11
Market Cap
C$33.74M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
29.44M15.78M+215.55%
Dec 31, 2023
13.66M11.10M+533.69%
Dec 31, 2022
2.56M2.36M+1,305.62%
Dec 31, 2021
196.00K188.00K+2,450.31%
Dec 31, 2020
8.00K-800,000.00%
Dec 31, 2019
Dec 31, 2018